SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home ▸ Investors ▸ Corporate Governance ▸ Governance Structure
Syngene is a professionally managed company functioning under the overall supervision of the board, which is the apex body constituted by shareholders. The board provides strategic guidance, direction and independence to the Management to achieve the overall corporate objectives for value creation through sustainable profitable growth.
The managing director & chief executive Officer (MD & CEO) is in overall operational control and is responsible for the day-to-day working of the company. He lays down policy guidelines and ensures implementation of the decisions of the board of directors and its various committees and functions under the superintendence, direction and control of the board. He is supported by the executive committee (EC).
© 2023. Syngene International Limited